Retatrutide 30mg + Kit

Retatrutide 30mg + Kit: A research-grade package containing 15mg of Retatrutide, a triple agonist peptide targeting GLP-1, GIP, and glucagon receptors, and a reconstitution kit for preparing the peptide for use. Retatrutide promotes significant weight loss by suppressing appetite, increasing energy expenditure, and improving insulin sensitivity, with potential benefits for metabolic and cardiovascular health. The reconstitution kit typically includes bacteriostatic water (e.g., 3ml vial), insulin syringes, a mixing syringe, and alcohol prep pads to facilitate sterile preparation and administration of the lyophilized peptide for research purposes.

Retatrutide + Kit

What is Retatrutide + Kit?

Retatrutide + Kit is a research-grade package containing Retatrutide, a triple agonist peptide targeting GLP-1, GIP, and glucagon receptors, and a reconstitution kit for preparing the peptide for use. Retatrutide promotes significant weight loss, improves insulin sensitivity, and enhances metabolic health by suppressing appetite, increasing energy expenditure, and regulating glucose and lipid metabolism. The reconstitution kit includes supplies to ensure sterile preparation of the lyophilized peptide for research purposes.

How It Works (Mechanism of Action)

Retatrutide activates three key receptors:

• GLP-1 Receptor: Enhances insulin secretion, delays gastric emptying, and reduces appetite, promoting satiety and lower caloric intake.
• GIP Receptor: Improves glucose-dependent insulin release and fat metabolism, enhancing metabolic efficiency.
• Glucagon Receptor: Stimulates lipolysis (fat breakdown) and increases energy expenditure, targeting visceral fat stores.

This triple-agonist mechanism amplifies weight loss, improves glycemic control, and supports cardiovascular and metabolic health, distinguishing it from single or dual agonists like semaglutide or tirzepatide.

Potential Benefits & Use Cases

• Significant Weight Loss: Clinical studies show up to 17.5% weight reduction over 24 weeks and 24.2% over 48 weeks, surpassing many existing therapies.

[](https://www.peptidesinstitute.org/retatrutide)

• Improved Glycemic Control: Enhances insulin sensitivity and regulates blood sugar, beneficial for type 2 diabetes research.
• Metabolic Health: Boosts fat oxidation and energy expenditure, improving lipid profiles and overall metabolic function.
• Cardiovascular Benefits: Early studies suggest potential improvements in cholesterol and reduced cardiovascular risk.
• Research Applications: Studied for obesity, metabolic disorders, and related conditions like sleep apnea and osteoarthritis.

Typical Dosage & Administration

Administration: Subcutaneous injection, typically once weekly, with the reconstitution kit facilitating sterile preparation.

Reconstitution Process:

• Kit Contents: Typically includes a 3ml vial of bacteriostatic water, 8 insulin syringes (0.5-1ml, 27-31 gauge), 1 mixing syringe (e.g., 3cc, 20-25 gauge), and 8 alcohol prep pads.

[](https://www.purerxpeptides.com/product-page/starter-kit-60-day-retatrutide)

• Steps: Disinfect vials with alcohol pads, draw 1-2 ml bacteriostatic water with the mixing syringe, slowly inject along the vial wall to minimize foam, gently swirl (do not shake), and store at 2-8°C. Use within 30 days; avoid freeze-thaw cycles.

[](https://peptidedosages.com/single-peptide-dosages/retatrutide-10mg/)

• Concentration Example: Reconstituting 15mg with 1.5ml water yields 10mg/ml (1000mcg = 0.1ml). For a 2.5mg dose, draw 0.25ml (25 units on a 1ml, 100-unit syringe).

[](https://www.reddit.com/r/Retatrutide/comments/1ix1lxv/reconstitution_and_calculation/)

Dosage:

• Starting Dose: Typically 0.5-2.5mg per week, gradually increased to minimize side effects like nausea or dizziness.

[](https://nulevelwellnessmedspa.com/retatrutide-dosage/)[](https://peptidedosages.com/single-peptide-dosages/retatrutide-10mg/)

• Maintenance Dose: Ranges from 5-15mg weekly, depending on research protocol and subject response, often titrated over weeks.

[](https://nulevelwellnessmedspa.com/retatrutide-dosage/)

• Protocol Example: Start at 0.5mg/week, increase to 2.5mg by week 5, and adjust up to 8-12mg for higher doses, using 1ml reconstitution for concentrated solutions (e.g., 12mg = 1.2ml).

[](https://peptidedosages.com/single-peptide-dosages/retatrutide-10mg/)

Possible Side Effects

• Gastrointestinal Issues: Nausea, diarrhea, or vomiting, most common during dose escalation, typically subsiding over time.

[](https://nulevelwellnessmedspa.com/retatrutide-dosage/)

• Dizziness: Mild dizziness or lightheadedness, particularly at higher doses.
• Injection Site Reactions: Slight redness or irritation, minimized with proper sterile technique.
• Rare Hypoglycemia: Possible in subjects with metabolic conditions, requiring monitoring.

Side effects are generally mild and manageable with proper dose titration and professional oversight.

Other Relevant Details

• Research Status: Investigational peptide under phase 3 trials (TRIUMPH program) for obesity, type 2 diabetes, and related conditions; not yet FDA-approved.

[](https://www.peptidesinstitute.org/retatrutide)

• Storage: Lyophilized vials stored at -20°C long-term or 4°C short-term; reconstituted solutions at 2-8°C for up to 30 days.

[](https://www.peptidesciences.com/retatrutide-6mg)

• Kit Utility: Simplifies preparation for multiple doses (e.g., 15mg vial can yield 6 doses of 2.5mg or 3 doses of 5mg).

[](https://www.reddit.com/r/Retatrutide/comments/1ix1lxv/reconstitution_and_calculation/)

• Purity: Typically ≥99% purity, verified by third-party testing, ensuring reliability for research.

[](https://aminousa.com/products/retatrutide-15mg)

• Not for Human Consumption: Intended solely for laboratory or in-vitro research, per supplier guidelines.

[](https://aminousa.com/products/retatrutide-15mg)